The European Stroke Organisation Conference (ESOC) 2018 took place between 16-18 May in Gothenburg, Sweden. The third day of ESOC featured new research which identified how to improve stroke care worldwide – from simple measures in low to middle-income countries, through to refinement of advanced techniques for acute and preventative stroke treatments.
We have compiled the state of atrial fibrillation care for each CCG in England. How is AF care in your CCG?
A haemorrhagic stroke is a stroke that is caused by bleeding in or around the brain. Although they are less common than strokes that are caused by a blockage, they can be much more serious.
The European Stroke Organisation Conference (ESOC) 2018 is currently on from 16-18 May in Gothenburg, Sweden. The first day of ESOC included some truly inspiring scientific sessions, including the WAKE-UP trial, RIGHT-2 trial and CROMIS-2 trials.
Browse through a list of organisations that can provide support and information about reducing the risk of stroke.
Information about atrial fibrillation for healthcare and other professionals.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
People with a type of irregular heartbeat called atrial fibrillation (AF) are five times more likely to have a stroke. This guide explains what AF is diagnosed, how it increases your risk of stroke and how it is treated.
Atrial fibrillation is a type of irregular heartbeat that can cause blood clots to form in your heart. Having atrial fibrillation increases your risk of stroke by five times.
You might be prescribed blood-thinning medication to reduce your risk of a TIA or stroke. This guide explains the two types of blood-thinning medication available, antiplatelets and anticoagulants, and how they are used after a stroke or for someone with atrial fibrillation.